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Fluorescent or metal halide lamps are widely used in therapeutic applications in dermatological diseases, with broadband or
narrow band emission UVA/UVA1 (320–400 nm) obtained with suitable passive filters. Recently, it has been possible for us to
use a new machine provided with solid state source emitting pulsed monochromatic UVA1 355 nm. In order to evaluate the
effects of this emission on immunocells of the skin, human skin samples were irradiated with monochromatic 355 nm UVA1 with
different energetic fluences and after irradiation Langerhans cells were labeled with CD1a antibodies. The immunohistochemical
identification of these cells permitted evaluating theirmodifications in terms of density into the skin. Obtained results are promising
for therapeutical applications, also considering that a monochromatic radiation minimizes thermic load and DNA damage in the
skin tissues.
1. Introduction
Langerhans cells are immunocompetent cells located in the
epidermis of the skin. These cells have been provided with
cytoplasmic processes intermingled with keratinocytes; they
do not contain keratin and do not form desmosomes with
keratinocytes. They represent a pool of cells which are part
of the peripheral immunosystem playing a specific role
in the pathogenesis of some inflammatory diseases of the
skin including psoriasis [1, 2]. Langerhans cells are directly
involved in the starting step of the complex mechanism of
detection, processing of antigens contacting epidermis, and
presentation of processed antigens to lymphocytes, with a
crucial role as peripheral sentinels.
The use of nonionizing radiations, particularly in the UV
range as elective treatment targeting Langerhans cells ofmany
skin inflammatory diseases, has been extensively studied and
applied in clinical practice [3].
Many devices using sources emitting wave lengths in
the UV (A, B, and C), in the visible or infrared range
targeting Langerhans cells, have been extensively used in
clinical applications concerning atopic dermatitis, mycosis
fungoides, scleroderma, lupus erythematosus, and psoriasis.
However, the wavelengths and energetic fluences have to
be tuned to the specific absorption characteristics of the
irradiated tissues.
As different new devices have been recently introduced,
we have studied and evaluated the effects of a pulsed
monochromatic UVA1 treatment on Langerhans cells.These
cells were identified with immunohistochemical method as
CD1a-positive cells for CD1a (Cluster of Differentiation 1a
antigen). Langerin is also a Langerhans cells marker but is
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expressed in mature cells. In histochemical preparations, the
number of langerin-positive cells is lower than the number
of CD1a-positive cells in the skin [4, 5], and therefore
the evaluation of CD1a-positive cells was more suitable for
morphometric evaluation of the UVA1 treatment effects on
the eyelid skin here used.
2. Material and Methods
Eyelid samples from healthy subjects collected after surgical
excision were irradiated (UVA1 355 nm) for 2min, 3min,
and 4min for a total transmitted energies, respectively, of
50, 75, and 100 J/cm2 and maintained with control samples
100%UVA1 protected (0 J/cm2) for 1 hour at 37∘C in a culture
medium optimized for skin [6].
For treatment, the energy UVA1 was produced by Alba
355 (EVLASER, Italy) based on a solid state laser (DPSS:
Diode Pumped Solid State laser) used as an active medium
and a coupled neodymium-doped yttrium orthovanadate
(Nd:YVO4) crystal. The light emitted by the Nd:YVO4
at a wavelength of 1064 nm is sent to a crystal separator
of 1064 nm harmonic components, particularly the second
(532 nm) and the third (355 nm). By cutting off the second
harmonic, the third harmonic emitted was filtered on. In this
manner an emission of a single wavelength of 355 nm was
obtained, as the UVA1 monochromatic wavelength used in
this study.
After treatment, samples were fixed with a paraformalde-
hyde 4% solution PBS buffered, in order to obtain not only
a good morphology but also the preservation of Langerhans
cells specific antigens. Skin samples were then processed
for microscopy through treatments of dehydration, paraffin
embedding,microtome sectioning, rehydration, hematoxylin
and eosin staining, last dehydration, and mounting on slides
for observation. Particular care was used for a correct
orientation of specimens in the embedding and sectioning
procedures in order to have sections perfectly perpendicular
to the skin surface.
Microscopic observations and digital recordings were
made at a lightmicroscopeCarl ZeissAxiophot providedwith
a 5-megapixel CCD camera Nikon DS-Fi2.
2.1. Immunohistochemistry. Antigenicity of the specific
markers molecules, in particular CD1a (Cluster of Differenti-
ation 1a), was well preservedwith the fixative we have used, so
immunohistochemistry with anti-CD1a antibody permitted
the identification of Langerhans cells in the skin [7]. Tissue
sections for immunohistochemistry were reacted withmouse
monoclonal antibody anti-CD1a (DAKO, Agilent Technolo-
gies, USA). Slides were baked for 1 hour at 50∘C, deparaf-
finized, and hydrated through a series of ethanol solutions at
decreasing concentration to water. Slides were then treated
with 0.05% Tween 20 in tris buffered saline for 5 minutes to
permeabilize tissues and washed in tris buffered saline. Slides
were heated in steamer in 1mmol/L EDTA buffer (pH 8.0) or
10mmol/L sodium citrate buffer (pH 6.0) for 20 minutes for
antigen retrieval and treated with 3% hydrogen peroxide for
10 minutes to quench endogenous peroxidase activity. After
washing with tris buffered saline, the slides were incubated
with the primary antibody for 30 minutes at room tempera-
ture and then incubated with Envision1 (DAKO Corp.) anti-
mouse labeled polymer conjugated with horseradish peroxi-
dase for 20minutes at room temperature.The immunolabel-
ing reaction was revealed using DAB1 (Sigma-Aldrich, USA),
and the sections were counterstained with hematoxylin. All
immunohistochemical staining procedures were performed
on an Autostainer Plus DAKO (DAKO Corp.).
2.2. Image Analysis. The selective immunocytochemistry
staining not only permitted the identification of Langerhans
cells but also permitted the application of a computerized
morphometric analysis using ImageJ (NIH), a well-known
software recognized as standard tool by international scien-
tific community.
Computerized morphometric analysis was performed
on immunostained sections with a thickness of 8휇m, with
a sampling area of 4 sqmm for each skin sample. Each
section was digitally recorded at the microscope through a
5Mpixels ccd camera at the same magnification and in the
identical conditions of the color temperature of the light
source. Resulting microphotographs were used for ImageJ
morphometric analysis with the following steps:
(1) Equalization of the image extended to the level limits
of 0 and 255 in order to detect and acquire, at the
same extent for all slides, the finest structural stained
details for the best selection of Langerhans cells in
their whole extension.
(2) Segmentation of the continuous tone image is defin-
ing the most suitable threshold segmentation value
for obtaining a binary image representing faithfully
the Langerhans cells over a background of ker-
atinocytes. For maintaining the full reliability of the
specimens comparisons, the threshold valueswere the
same for all slides.
(3) Measurements and collection of data and quantitative
evaluation were performed. All results are presented
in graph as mean percentage ± standard deviation
in Figure 3. Statistical analysis was performed com-
paring samples with Student’s 푡-test. Differences were
considered significant at 푝 < 0,01.
3. Results
Skin samples were UVA1 irradiated with energy fluences
of 50, 75, and 100 J/cm2, and controls were 100% UVA1
protected (0 J/cm2). They were processed for histology and
histochemistry all together in each step of the procedures,
in order to minimize possible differences due to technical
reasons and to assure a reliable comparative analysis.
In Figure 1, immunostaining and image analysis of a
control section are reported. In Figure 1(a), Langerhans cells,
body, and cytoplasmic processes, labeled by specific antibody
for CD1a, appear clearly visible (brown) on the background
of keratinocytes faintly stained with hematoxylin. Figure 1(b)
is representing the segmentation of the continuous tone
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Figure 1: More relevant steps of the image analysis procedure illustrated on a skin control sample. (a) Immunohistochemical analysis
identified CD1a-positive Langerhans cells (brown) on a background of keratinocytes faintly hematoxylin stained. (b) Continuous tone image
with labeled CD1a-positive Langerhans cells, blue masked following segmentation (inset), ready for digital conversion. (c) Binary image
resulting from digitalization where white areas are constituting the pool of pixels to be evaluated.
image through a passband digital filter with related blue
mask. Figure 1(c) shows the digitalized image where white
pixels are constituting the areas to be measured as percentage
of the 2560 × 1920 pixels standard reference frame. This
methodological way has been applied with the same seg-
mentation parameters to all sections obtained from controls
(Figures 2(a), 2(b), and 2(c), 100% protected) and from
specimens irradiated with energy fluences of 50, 75, and
100 J/cm2, respectively (Figures 2(d)–2(l)). Finally (Figures
2(c), 2(f), 2(i), and 2(l)), the white areas of the digital images
representing CD1a-positive Langerhans cells were measured,
as percentage of the full area of the same reference frame.
The results of the measurements are reported as Figure 3,
where the immunoreactivity for CD1a, covering 8,34% (SD±1,12) of the frame in controls, appears to be reduced to
4,37% (SD±1,24) at 50 J/cm2, to 3,18% (SD±0,86) at 75 J/cm2,
and to 0,73% (SD ± 0,48) at 100 J/cm2. Statistical analysis
between samples showed significative differences (푝 < 0,01,
asterisks in Figure 3). The reduction of the CD1a labeled
Langerhans cells areas is related to the energetic fluence, with
amaximal reduction after treatment with energetic fluence of
100 J/cm2.
4. Discussion and Conclusions
The fluorescent lamps have low irradiance (5–10W/cm2)
and delivery low UVA dose in long time (10–30 J/cm2).
High-output metal halide source has a much greater irradi-
ance (80W/cm2) and can irradiate medium or high doses
in treatment sessions of 50min. Conventional machines for
UVA treatment emit wavelengths mainly between 340 and
400 nm but may also produce scattered radiation >530 nm
including infrared irradiation (780–3000 nm). Conventional
UVA phototherapy may be accompanied by extensive heat
load predominantly generated by infrared irradiation (780–
3000 nm) and/or insufficient cooling systems of the pho-
totherapy devices.
Light therapy lamps with halogen-metal band confined
to the very high irradiance UVA1 (340–400 nm) have expe-
rienced a growing success and interest [8]. Unlike UVA2 and
UVB (290–340 nm), the biological effects ofUVA1 on the skin
are mainly related to oxidative stress, mediated by aerobic
photooxidation with the intermediate formation of reactive
oxygen species such as singlet oxygen, superoxide anion, and
hydroxyl radicals [9–11].
About 37% of Caucasian UVA1 irradiation penetrates
deeply in the skin up to 60–90mm and therefore these
wavelengths can effectively modulate the activity of immune
and inflammatory cell populations resident or patrolling the
epidermis and the dermis.
UVA1may induce apoptosis of T lymphocytes, especially
T helper, not only through late mechanisms dependent on
a synthesis de novo of some proteins but also through
mechanisms that are early, preprogrammed, and independent
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Figure 2:The same procedure of Figure 1 was applied to all samples: control (a, b, and c), and samples irradiated with fluences of 50, 75, and
100 J/cm2, respectively (d–l). Columns identify original images (a, d, g, and j), segmented images (b, e, h, and k), and digital images (c, f, i,
and l).
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Figure 3: Percentage of CD1a-positive Langerhans cells in skin
control and treated with monochromatic UVA1 355. Results of the
measurements, where the units represent the percentage areas occu-
pied by CD1a-positive Langerhans cells in controls and irradiated,
respectively, over the same reference areas. Student’s 푡-test results: ∗
versus ∗∗, ∗∗ versus ∗∗∗, and ∗∗∗ versus ∗∗∗∗, for all 푝 < 0,01.
of theUVA1 proteins synthesis.This is causing the production
of PGE2 and thromboxane in the cells of Langerhans but does
not alter the number and function and induces migration in
satellite lymph nodes [3].
The recent availability of a machine emitting pulsed
monochromaticUVA1 355nmwavelength (Alba 355) allowed
evaluating the effects of such irradiation on CD1a-positive
Langerhans cells, considering that a monochromatic radia-
tion minimizes collateral effects in the irradiated tissues.The
radiation used (not a broad or narrow band but a monochro-
maticwave) and the very short time of single pulses permitted
a much better control of the energy transfer to the skin. In
this way, at the same time, it minimizes thermal surcharge
of tissues and risks related to DNA damage, with pyrimidine
dimers formation [12]. Our experimental model has been
eyelid skin fragments freshly excised andmaintained in short
term organotypic culture (one hour, comprehensive of the
short time of irradiation). The protocols for UVA1 355 nm
phototherapy of skin samples involved the irradiation of
single specimens with 50, 75, and 100 J/cm2, respectively, and
specimens 100% protected as control.
As the most common and reliable antigen for the histo-
chemical identification of Langerhans cells in the epidermis,
we have considered the CD1a antigen, a transmembrane
glycoprotein structurally related to the Major Histocom-
patibility Complex (MHC) protein antibody currently used
as specific marker of these cells [13]. CD1a, also expressed
on macrophages on the connective tissue, is highly specific
for Langerhans cells in the epidermis and used in routine
dermatological diagnostic practice. Our in vitro experimental
condition of the skin samples and the short time follow-
ing irradiation did not permit considering the possible
migration of these cells in the dermis and towards lymph
nodes.
Our results are demonstrating significant modifications
of the percentage of anti-CD1a labeled cells in the epithelium
of skin treated with specific 355 nm monochromatic wave-
length, with an effect energy-transfer dependent, minimizing
collateral adverse effects on DNA differently from wide
spread UVA applications in dermatological diseases [11].
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